Pulmonary Function Changes in 10 Pack Year Smokers With Chronic Bronchitis
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
To determine whether an average population of males and females who smoke 10 pack years or more of cigarettes in a primary care setting with chronic bronchitis has already developed significant changes on pulmonary function testing.
Condition or disease
The incident of COPD is dramatically increasing while other chronic disease states are decreasing in the US population. Smoking cigarettes is the leading risk factor for COPD. Smokers with chronic bronchitis may show early or late changes of COPD on pulmonary function tests. It is imperative that we define this patient population to determine whether early intervention will alter pulmonary function over the years.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
40 Years to 80 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subjects must sign a written informed consent.
Enrollment population would include males and females 40 years of age to 80 years of age.
Current history or past history of smoking at least 10 pack years of cigarettes.
Patients to satisfy the diagnosis of chronic bronchitis.
Non-smokers will be allowed in the control group
Chronic infections such as TB or other infections of the lungs.
Collagen diseases such as rheumatoid arthritis or lupus which affect the lungs.
Any previous lung diseases such as pneumoconiosis.
Previous accidents or surgery which would involve the lungs or the ribcage.
Maintenance medications used for asthma or COPD such as long acting bronchodilators or inhaled corticosteroids.
Asthma patients or other patients with allergies that may affect pulmonary function test will be excluded.
Any medical condition in the opinion of the investigator that would make the subject unsuitable for enrollment.
Pregnant woman will not be allowed
Current participation in a research study or within the last 30 days.